Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Sun, Yuan Shui ^a   Ye, Zai Yuan ^a   Qian, Zhen Yuan ^a   Xu, Xiao Dong ^a   Hu, Jun Feng ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Cachexia; Gastric cancer; Mrna; Skeletal muscle; TRAF6; Ubiquitin

Indexed keywords

ALBUMIN; MESSENGER RNA; PROTEASOME; SERUM ALBUMIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN;

ABDOMINAL DISEASE; ADULT; AGED; ARTICLE; CACHEXIA; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECTUS ABDOMINIS MUSCLE; SKELETAL MUSCLE; STOMACH CANCER; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CACHEXIA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RNA, MESSENGER; STOMACH NEOPLASMS; TNF RECEPTOR-ASSOCIATED FACTOR 6; UBIQUITIN;

EID: 84866529888     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-81     Document Type: Article

References (15)

1. Cancer-induced cachexia: a guide for the oncologist. Gullett N, Rossi P, Kucuk O, Johnstone PA, J Soc Integr Oncol 2009 7 4 155 169 19883531
2. Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Evans WJ, Am J Clin Nutr 2010 91 4 1123S 1127S 10.3945/ajcn.2010.28608A 20164314
3. Cachexia: a new definition. Evans WJ, Morley JE, Argilés J, et al. Clin Nutr 2008 27 6 793 799 10.1016/j.clnu.2008.06.013 18718696
4. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Dodson S, Baracos VE, Jatoi A, et al. Annu Rev Med 2011 62 265 279 10.1146/annurev-med-061509-131248 20731602
5. Cancer-associated cachexia and underlying biological mechanisms. Baracos VE, Annu Rev Nutr 2006 26 435 461 10.1146/annurev.nutr.26.061505.111151 16602932
6. Mechanisms of cancer cachexia. Tisdale MJ, Physiol Rev 2009 89 2 381 410 10.1152/physrev.00016.2008 19342610
7. Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of counter measures. Chopard A, Hillock S, Jasmin BJ, J Cell Mol Med 2009 13 9B 3032 3050 10.1111/j.1582-4934.2009.00864.x 19656243
8. Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Kubrak C, Olson K, Jha N, et al. Head Neck 2010 32 3 290 300 19626639
9. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. Paul PK, Gupta SK, Bhatnagar S, et al. J Cell Biol 2010 191 7 1395 1411 10.1083/jcb.201006098 21187332
10. TWEAK and TRAF6 regulate skeletal muscle atrophy. Kumar A, Bhatnagar S, Paul PK, Curr Opin Clin Nutr Metab Care 2012 15 3 233 239 10.1097/MCO. 0b013e328351c3fc 22366923
11. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Onodera T, Goseki N, Kosaki G, Nippon Geka Gakkai Zasshi 1984 85 1001 6438478
12. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Bossola M, Muscaritoli M, Costelli P, Grieco G, Bonelli G, Pacelli F, Rossi Fanelli F, Doglietto GB, Baccino FM, Ann Surg 2003 237 3 384 389 12616123
13. Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies. Baracos VE, Cancer 2001 92 6 Suppl 1669 1677 11598885
14. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Bossola M, Muscaritoli M, Costelli P, et al. Ann Surg 2003 237 3 384 389 12616123
15. TRAF6 coordinates the activation of autophagy and ubiquitin-proteasome systems in atrophying skeletal muscle. Paul PK, Kumar A, Autophagy 2011 7 5 555 556 10.4161/auto.7.5.15102 21412053